ETIZOLA
Manufacturer Details
MACLEODS
Compositions:
Etizolam 0.25mg/0.50mg/1mg ,
|
Strength
|
Rate
|
Packing Style
|
|
0.25mg
|
34.00
|
10s Film coated tablets
|
|
0.50mg
|
49.00
|
10s Film coated tablets
|
|
1mg
|
72.50
|
10s Film coated tablets
|
List of Related Indications:
- Anxiety
- Hyperthyroidism
- Preoperative surgery
List Of Drugs:
Indication Type Description:
Pharmacology/ Pharmacokinetics
Indication:
LIST OF DRUGS DURING 2007
Sr.No- 153
Name of the Drug- Etizolam Tablet (0.5mg/1mg) Pharmacological Classification- For anxiety disorder associated with depression
Date of Approval- 29-10-07
Approved by U.S.FDA on 30-12-2007 (Ref- FDA approved List- 2007)
Approved by (DCI) Drug Controller GENERAL - India For Marketing
(Ref- IDMA Publication)
Name of Drug Indication Date of Approval
1.Etiozolam 0.25mg tablet 03-07-2010
Addl.Stgth
Same as approved
2.Etiozolam Tablet 0.5mg/1mg) 29-10-2007
For Anxiety Disorder Associated with depression
Anxiety
Hyperthyroidism
Preoperative surgery
Adverse Reaction:
Muscle weakness, insomnia, impotence
Gastrointestinal disturbances,
Fatigue, dizziness , insomnia
Vivid dreams, alterations in mood and thought
Daytime hallucinations and skin rashes
Contra-Indications:
Increased ey pressure
Sleep disorder
Severe liver impairment
Porphyria and hypersensitivity
Bronchospasm
Catdiogenic shock
Second or third degree heart attack
Hypoglycemia or pronged fasting
Severe hemorrhage and metabolic acidosis
Dosages/ Overdosage Etc:
Date of Approval 2007
Indication-
Anxiety
Hyperthyroidism
Preoperative surgery
Dosage-
One tablet twice daily of either Etizolam 0.25mg or 0.5mg + Propranol 20mg
Pharmacology/ Pharmacokinetics:
Pharmacodynamics -
Etizolam a short acting benzodizepine is type A receptors associated with anxiety.
Propranolol produces its anxiolytic property by the blockade of effects of adrenaline
at beta -receptors
